JP2022552009A5 - - Google Patents
Info
- Publication number
- JP2022552009A5 JP2022552009A5 JP2022523031A JP2022523031A JP2022552009A5 JP 2022552009 A5 JP2022552009 A5 JP 2022552009A5 JP 2022523031 A JP2022523031 A JP 2022523031A JP 2022523031 A JP2022523031 A JP 2022523031A JP 2022552009 A5 JP2022552009 A5 JP 2022552009A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025185622A JP2026012402A (ja) | 2019-10-18 | 2025-11-04 | 薬物送達のための脂質及び脂質ナノ粒子製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962923258P | 2019-10-18 | 2019-10-18 | |
| US62/923,258 | 2019-10-18 | ||
| PCT/US2020/056252 WO2021077066A1 (en) | 2019-10-18 | 2020-10-19 | Lipid and lipid nanoparticle formulation for drug delivery |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025185622A Division JP2026012402A (ja) | 2019-10-18 | 2025-11-04 | 薬物送達のための脂質及び脂質ナノ粒子製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022552009A JP2022552009A (ja) | 2022-12-14 |
| JP2022552009A5 true JP2022552009A5 (https=) | 2023-10-23 |
| JPWO2021077066A5 JPWO2021077066A5 (https=) | 2023-10-23 |
Family
ID=75538682
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523031A Pending JP2022552009A (ja) | 2019-10-18 | 2020-10-19 | 薬物送達のための脂質及び脂質ナノ粒子製剤 |
| JP2025185622A Pending JP2026012402A (ja) | 2019-10-18 | 2025-11-04 | 薬物送達のための脂質及び脂質ナノ粒子製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025185622A Pending JP2026012402A (ja) | 2019-10-18 | 2025-11-04 | 薬物送達のための脂質及び脂質ナノ粒子製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220396556A1 (https=) |
| EP (1) | EP4045020A4 (https=) |
| JP (2) | JP2022552009A (https=) |
| KR (1) | KR20220084365A (https=) |
| CN (1) | CN114828836A (https=) |
| AU (1) | AU2020368556A1 (https=) |
| CA (1) | CA3155074A1 (https=) |
| WO (1) | WO2021077066A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL303195A (en) | 2020-11-25 | 2023-07-01 | Akagera Medicines Inc | Lipid nanoparticles for delivery of nucleic acids and related methods of use |
| CN113785975B (zh) * | 2021-09-09 | 2023-08-29 | 天津医科大学 | 精胺、亚精胺脂质体在抗氧化、抗衰老中的应用 |
| AR128959A1 (es) * | 2022-04-04 | 2024-06-26 | Spark Therapeutics Inc | Mejora inmunológica del tratamiento del cáncer |
| US20230322689A1 (en) * | 2022-04-08 | 2023-10-12 | SunVax mRNA Therapeutics Inc. | Ionizable lipid compounds and lipid nanoparticle compositions |
| EP4531819A2 (en) | 2022-05-25 | 2025-04-09 | Akagera Medicines, Inc. | Lipid nanoparticles for delivery of nucleic acids and methods of use thereof |
| WO2024061354A1 (zh) * | 2022-09-23 | 2024-03-28 | 北京键凯科技股份有限公司 | 一种抑制top1基因表达的干扰rna及其应用 |
| AU2024231082A1 (en) * | 2023-03-09 | 2025-10-16 | Maxirna (Shanghai) Pharmaceutical Co., Ltd. | Ionizable lipid molecule, preparation method therefor and use thereof |
| CN116082184B (zh) * | 2023-04-12 | 2023-06-30 | 山东大学 | 基于环己二胺的可电离脂质、脂质纳米颗粒及其制备方法与应用 |
| WO2025038494A1 (en) | 2023-08-11 | 2025-02-20 | Tune Therapeutics, Inc. | Compositions, systems, and methods for lymphoid cell differentiation using targeted gene activation |
| WO2025059112A1 (en) * | 2023-09-11 | 2025-03-20 | The Trustees Of The University Of Pennsylvania | Compositions and methods for t cell targeted extrahepatic delivery of therapeutic agents |
| CN117482066B (zh) * | 2023-11-02 | 2024-08-13 | 深圳市易瑞生物技术股份有限公司 | 脂质组合物和用于脂质组合物的化合物 |
| WO2025209467A1 (en) * | 2024-04-01 | 2025-10-09 | Longuide Biopharma Corporation | Lipids and lipid nanoparticle formulations |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104119242B (zh) * | 2008-10-09 | 2017-07-07 | 泰米拉制药公司 | 改善的氨基脂质和递送核酸的方法 |
| ES2646630T3 (es) * | 2008-11-07 | 2017-12-14 | Massachusetts Institute Of Technology | Lipidoides aminoalcohólicos y usos de los mismos |
| US7635707B1 (en) * | 2008-11-10 | 2009-12-22 | Intermune, Inc. | Pirfenidone treatment for patients with atypical liver function |
| WO2015011633A1 (en) * | 2013-07-23 | 2015-01-29 | Protiva Biotherapeutics, Inc. | Compositions and methods for delivering messenger rna |
| WO2018081638A1 (en) * | 2016-10-27 | 2018-05-03 | The Trustees Of The University Of Pennsylvania | Nucleoside-modified rna for inducing an adaptive immune response |
-
2020
- 2020-10-19 AU AU2020368556A patent/AU2020368556A1/en active Pending
- 2020-10-19 WO PCT/US2020/056252 patent/WO2021077066A1/en not_active Ceased
- 2020-10-19 CA CA3155074A patent/CA3155074A1/en active Pending
- 2020-10-19 KR KR1020227016630A patent/KR20220084365A/ko not_active Ceased
- 2020-10-19 US US17/769,858 patent/US20220396556A1/en active Pending
- 2020-10-19 JP JP2022523031A patent/JP2022552009A/ja active Pending
- 2020-10-19 CN CN202080088019.XA patent/CN114828836A/zh active Pending
- 2020-10-19 EP EP20877084.2A patent/EP4045020A4/en active Pending
-
2025
- 2025-11-04 JP JP2025185622A patent/JP2026012402A/ja active Pending